Topical treatment of venereal warts: A comparative open study of podophyllotoxin cream versus solution

International Journal of STD and AIDS

Volumn 7, Issue 6, 1996, Pages 429-434

  Claesson, Urban ^a,d   Lassus, Allan ^b   Happonen, Hanno ^b   Hogström, Lars ^a   Siboulet, Antoine ^c  

^a Vasastadens Läkarmottgn   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c INSTITUT ALFRED FOURNIER   (France)

^d Urban Claesson   (Sweden)

Author keywords

Condyloma acuminata; Podophyllotoxin cream; Topical treatment

Indexed keywords

PODOPHYLLOTOXIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; KERATOLYTIC AGENTS; MALE; OINTMENTS; PENILE DISEASES; PODOPHYLLOTOXIN; RECURRENCE; SOLUTIONS; VULVAR DISEASES;

EID: 0029798194     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462961918400     Document Type: Article

References (23)

1. Department of Health and Social Security: sexually transmitted diseases. Br J Vener Dis 1984;60:199-203
2. Manso-Marinez R. Podophyllotoxin poisoning of microtubules at steady-state: effect of substoichiometric and superstoichiometric concentrations of drug. Mol Cell Biochem 1982;45:3-11
3. Loike JD, Horowitz SB. Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells. Biochemistry 1976;15:5435-42
4. Beutner KR, Conant MA, Friedman-Kien AE, et al. Patientapplied podofilox for treatment of genital warts. Lancet 1989;i:831-4
5. Greenberg MD, Rutledge LH, Reid R, et al. A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol 1991;77:735-9
6. von Krogh G. Podophyllotoxin for condyloma eradication. Acta Derm Verneriol (Stockh) 1981;98(suppl):1-48
7. von Krogh G. Penile condyloma acuminata: an experimental model for evaluation of topical self-treatment with 0.5-1% ethanolic preparations of podophyllotoxin for three days. Sex Transm Dis 1981;8:179-86
8. von Krogh G, Hellberg D. Self-treatment using a 0.5% podophyllotoxin cream of external genital condylomata acuminata in women. Sex Transm Dis 1992;19(3):170-4
9. Pickering RW. Self-treatment of genital warts using Warticon. Br J Sex Med 1989;16:320-4
10. Edwards A, Ram A, Thin RN. Podophyllotoxin 0.5% vs podophyllin 20% to treat penile warts. Genitourin Med 1988;64:263-5
11. Lassus A. Comparison of podophyllotoxin and podophyllin in treatment of genital warts. Lancet 1987;29:512-13
12. 2)-laser therapy cures macroscopic lesions, but viral genome is not eradicated in men with therapy-resistant HPV infection. Sex Transm Dis 1994;21(6):297-302
13. Kraus S, Stone K. Management of genital infection caused by human papillomavirus. Rev Inf Dis 1990;12:620-32
14. Baggish M. Improved laser techniques for the elimination of genital and extragenital warts. Am J Obstet Gynecol 1985;153: 545-50
15. Duus B, Philipsen T, Christenen J, Lundvall F, Sondergård J. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourin Med 1985;61:59-61
16. Chow VTK, Tay SK, Tham KM, et al. Subclinical human papillomavirus infection of the male lower genital tract: colposcopy, histology and DNA analysis. Int J STD AIDS 1991;2:41-5
17. Barasso R, de Brux J, Croissant O, Orth G. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987;317:916-23
18. Epperson WJ. Preventing cervical cancer by treating genital warts in men. Why male sex partners need androscopy. Postgrad Med 1990;88:229-36
19. Syrjänen KJ. Epidemiology of human papillomavirus (HPV) infections and their association with genital squamous cell cancer. APMIS 1989;97:957-70
20. Syrjänen KJ, Hakama M, Saarikoski S, et al. Prevalence incidence and estimated life-time risk of cervical human papillomavirus (HPV) infection in nonselected Finnish female population. Sex Transm Dis 1990;17:15-19
21. Canin Endre J, Steinhagen RM. Lasers in anorectal surgery. Anorectal Surg 1994;74(6):1415-32
22. von Krogh G. Genitoanal papillomavirus infection: diagnostic and therapeutic objectives in the light of current epidemiological observations, Int J STD AIDS 1991;2:391-404
23. Jablonska S, Majewski S, Malejczyk J. HPV infection and immunological responses. In: von Krogh G, Rylander E, eds. GPV1. Genitoanal Papilloma Virus Infection. A Survey for the Clinicians. Karlstad, Sweden: Conpharm/Kabi, 1989;289-329